Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127654831 | 12765483 | 1 | I | 20160304 | 20160912 | 20160921 | 20160921 | EXP | US-AMGEN-USASL2016125132 | AMGEN | 87.00 | YR | E | F | Y | 64.85000 | KG | 20160921 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127654831 | 12765483 | 1 | PS | PROCRIT | ERYTHROPOIETIN | 1 | Subcutaneous | 40000 UNIT, QWK (40000 UNIT/ML SOLN, ONCE A WEEK) | 103234 | SOLUTION FOR INJECTION | /wk | ||||||||
| 127654831 | 12765483 | 2 | C | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | 5 MG, QD (ONCE DAILY 1-YR SUPPLY) | 0 | 5 | MG | TABLET | QD | |||||||
| 127654831 | 12765483 | 3 | C | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | 0.1 %, QD (APPLY TO AFFECTED AREA) | 0 | .1 | PCT | OINTMENT | QD | |||||||
| 127654831 | 12765483 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, QD (TAKE 1 TABLET BY MOUTH ONCE DAILY) | 0 | 100 | MG | TABLET | QD | ||||||
| 127654831 | 12765483 | 5 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 5 MG, BID (TWICE A DAY) | 0 | 5 | MG | TABLET | BID | |||||||
| 127654831 | 12765483 | 6 | C | ATENOLOL. | ATENOLOL | 1 | 50 MG, QD (ONCE DAILY) | 0 | 50 | MG | TABLET | QD | |||||||
| 127654831 | 12765483 | 7 | C | CALTRATE 600+D | 2 | UNK UNK, QD (600-400 MG UNIT TABS ONCE DAILY) | 0 | TABLET | QD | ||||||||||
| 127654831 | 12765483 | 8 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | UNK UNK, QD (ONCE DAILY) | 0 | TABLET | QD | |||||||||
| 127654831 | 12765483 | 9 | C | CLOBETASOL PROPIONATE. | CLOBETASOL PROPIONATE | 1 | 0.05 %, UNK (APPLY THIN LAYER TWICE A DAY X2 WEEKS, THEN DAILY X2 WEEKS, THEN THREE TIMES PER WEEKS) | 0 | .05 | PCT | OINTMENT | ||||||||
| 127654831 | 12765483 | 10 | C | FISH OIL | FISH OIL | 1 | 1000 MG, QD (CAPSUL 3 ONCE A DAY) | 0 | 1000 | MG | CAPSULE | QD | |||||||
| 127654831 | 12765483 | 11 | C | IRON | IRON | 1 | 325 MG, QD (325 (65 FE) MG TABS, 4 TABS QD) | 0 | 325 | MG | TABLET | QD | |||||||
| 127654831 | 12765483 | 12 | C | CYTOMEL | LIOTHYRONINE SODIUM | 1 | Oral | 5 MUG, QD (5 MCG TABLET TAKE ONE TABLET BY MOUTH ONCE DAILY, MID-AFTERNOON USE) | 0 | 5 | UG | TABLET | QD | ||||||
| 127654831 | 12765483 | 13 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 100 MUG, UNK (1 TABLET BY MOUTH QAM MONDAY -THURSDAY- THEN TAKE 0.5 TABLET) | 0 | 100 | UG | TABLET | |||||||
| 127654831 | 12765483 | 14 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 100 MG, QID (TAKE ONE TABLET BY MOUTH ONCE DAILY AT BEDTIME) | 0 | 100 | MG | TABLET | QID | ||||||
| 127654831 | 12765483 | 15 | C | NYSTATIN W/TRIAMCINOLONE | 2 | UNK, BID (100000-0.1 UNIT/GM-% CREA, USE AS DIRECTED APPLY TO AFFECTED AREA BID X 10-14 DAYS THEN) | 0 | BID | |||||||||||
| 127654831 | 12765483 | 16 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 20 MG, QD (20 MG TBEC, 1 ONCE DAILY) | 0 | 20 | MG | QD | ||||||||
| 127654831 | 12765483 | 17 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 108 MUG, Q4H (108 (90 BASE) MCG/ACT AERS, 2 PUFFS Q4H PRN) | 0 | 108 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127654831 | 12765483 | 1 | Product used for unknown indication |
| 127654831 | 12765483 | 2 | Diabetes mellitus |
| 127654831 | 12765483 | 3 | Psoriasis |
| 127654831 | 12765483 | 4 | Gout |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127654831 | 12765483 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127654831 | 12765483 | Back pain | |
| 127654831 | 12765483 | Body tinea | |
| 127654831 | 12765483 | Bursitis | |
| 127654831 | 12765483 | Contusion | |
| 127654831 | 12765483 | Dermatophytosis | |
| 127654831 | 12765483 | Diverticulum intestinal | |
| 127654831 | 12765483 | Eczema | |
| 127654831 | 12765483 | Essential hypertension | |
| 127654831 | 12765483 | Fall | |
| 127654831 | 12765483 | Gastrooesophageal reflux disease | |
| 127654831 | 12765483 | Haemoglobin decreased | |
| 127654831 | 12765483 | Hiatus hernia | |
| 127654831 | 12765483 | Hypertriglyceridaemia | |
| 127654831 | 12765483 | Injury | |
| 127654831 | 12765483 | Large intestine polyp | |
| 127654831 | 12765483 | Lichen planus | |
| 127654831 | 12765483 | Oedema peripheral | |
| 127654831 | 12765483 | Palpitations | |
| 127654831 | 12765483 | Rhinitis allergic | |
| 127654831 | 12765483 | Secondary hypothyroidism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127654831 | 12765483 | 1 | 20140924 | 0 |